<--- Back to Details
First PageDocument Content
Tuberculosis
Tuberculosis

FDA/AUA Panel NMIBC Are the current data that we have  regarding BCG efficacy of good  enough quality to establish a non‐ inferiority margin for trials today? Seth P. Lerner, MD, FACS

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 217,77 KB

Share Document on Facebook

Similar Documents